Skip to main navigation Skip to search Skip to main content

Central Nervous System Cancers, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology

  • Louis Burt Nabors
  • , Jana Portnow
  • , Manmeet Ahluwalia
  • , Joachim Baehring
  • , Henry Brem
  • , Steven Brem
  • , Nicholas Butowski
  • , Jian L. Campian
  • , Stephen W. Clark
  • , Andrew J. Fabiano
  • , Peter Forsyth
  • , Jona Hattangadi-Gluth
  • , Matthias Holdhoff
  • , Craig Horbinski
  • , Larry Junck
  • , Thomas Kaley
  • , Priya Kumthekar
  • , Jay S. Loeffler
  • , Maciej M. Mrugala
  • , Seema Nagpal
  • Manjari Pandey, Ian Parney, Katherine Peters, Vinay K. Puduvalli, Ian Robins, Jason Rockhill, Chad Rusthoven, Nicole Shonka, Dennis C. Shrieve, Lode J. Swinnen, Stephanie Weiss, Patrick Yung Wen, Nicole E. Willmarth, Mary Anne Bergman, Susan D. Darlow
  • University of Alabama at Birmingham
  • Case Western Reserve University
  • Yale University
  • Johns Hopkins University
  • University of Pennsylvania
  • University of California at San Francisco
  • Washington University St. Louis
  • Vanderbilt University
  • Roswell Park Comprehensive Cancer Center
  • University of South Florida
  • University of California at San Diego
  • Northwestern University
  • University of Michigan, Ann Arbor
  • Memorial Sloan-Kettering Cancer Center
  • Massachusetts General Hospital Cancer Center
  • Mayo Clinic
  • Stanford University
  • St. Jude Children Research Hospital
  • Duke University
  • Ohio State University
  • University of Wisconsin-Madison
  • Seattle Cancer Care Alliance
  • University of Colorado
  • University of Nebraska Medical Center
  • University of Utah
  • Dana-Farber Cancer Institute
  • American Brain Tumor Association
  • National Comprehensive Cancer Network
  • City of Hope National Medical Center

Research output: Contribution to journalReview articlepeer-review

393 Scopus citations

Abstract

The NCCN Guidelines for Central Nervous System (CNS) Cancers focus on management of adult CNS cancers ranging from noninvasive and surgically curable pilocytic astrocytomas to metastatic brain disease. The involvement of an interdisciplinary team, including neurosurgeons, radiation therapists, oncologists, neurologists, and neuroradiologists, is a key factor in the appropriate management of CNS cancers. Integrated histopathologic and molecular characterization of brain tumors such as gliomas should be standard practice. This article describes NCCN Guidelines recommendations for WHO grade I, II, III, and IV gliomas. Treatment of brain metastases, the most common intracranial tumors in adults, is also described.

Original languageEnglish
Pages (from-to)1537-1570
Number of pages34
JournalJournal of the National Comprehensive Cancer Network : JNCCN
Volume18
Issue number11
DOIs
StatePublished - Nov 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Adult
  • Astrocytoma/diagnosis
  • Brain Neoplasms/diagnosis
  • Central Nervous System
  • Central Nervous System Neoplasms/diagnosis
  • Glioma/diagnosis
  • Humans
  • Practice Guidelines as Topic

Fingerprint

Dive into the research topics of 'Central Nervous System Cancers, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology'. Together they form a unique fingerprint.

Cite this